Back to Journals » Journal of Multidisciplinary Healthcare » Volume 18

Associations of Dietary Live Microbes Intake and Prevalence of Prediabetes in US Adults: A Cross-Sectional Analysis

Authors Ge X, Du J, Wang J, Xi L, Gao J, Zhou P, Peng W, Huang S 

Received 18 November 2024

Accepted for publication 29 January 2025

Published 24 February 2025 Volume 2025:18 Pages 1135—1145

DOI https://doi.org/10.2147/JMDH.S507248

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr David C. Mohr



Xiaoxu Ge,1,* Juan Du,1,* Jiajia Wang,2,* Liuqing Xi,1 Jianfang Gao,2 Peng Zhou,2 Wenfang Peng,1 Shan Huang1,*

1Department of Endocrinology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People’s Republic of China; 2Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Shan Huang, Department of Endocrinology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China, Email [email protected]

Objective: A higher dietary intake of live microbes has been shown to be associated with a range of health benefits. We aimed to elucidate the associations between dietary intake of live microbes and the risk of prediabetes.
Methods: Adult participants from the 1999– 2018 US National Health and Nutrition Examination Survey were included and categorized into the low, medium, and high live microbe intake groups based on the Sanders classification system. Associations between dietary consumption of live microbes and prevalence of prediabetes were explored using univariate and multivariate logistic regression, stratified analysis, and sensitivity analysis.
Results: Among the 28201 participants (mean age 45.83 years, 48.40% men, 32.78% with prediabetes) included, 9761 (31.80%), 12,076 (41.42%) and 6364 (26.78%) were classified into the low, medium, and high dietary live microbe intake groups, respectively. After adjusting for all potential covariates, the odds ratios and 95% confidence intervals for the medium and high dietary live microbe intake groups were 0.868 (0.803– 0.937) and 0.891 (0.807– 0.983), respectively (P for trend = 0.017), with the low dietary live microbes intake group as the reference. This association is robust and not affected by participant’s age, sex, race, poverty–income ratio, education level, hypertension status and estimated glomerular filtration rate.
Conclusion: A higher consumption of dietary live microbes was found to be cross-sectionally linked to a lower prevalence of prediabetes in US adults.

Keywords: cross-sectional, live microbes, NHANES, prediabetes

Introduction

Prediabetes is considered to be an intermediary state of impaired glucose metabolism at risk of progressing to overt type 2 diabetes mellitus. The global prevalence of prediabetes was 9.1% and 5.8% in year 2021, which were expected to rise to 10.0% and 6.5% in 2045 based on criteria of impaired glucose tolerance and impaired fasting glucose, respectively, in people aged 20 to 79 years.1 Currently, various criteria have been proposed for the diagnosis of prediabetes. Specifically, the World Health Organization proposed a fasting blood glucose of 6.1–6.9 mmol/L or a 2-hour post-load plasma glucose of 7.8–11.0 as criteria for prediabetes, while the International Expert Committee also advocated a glycated hemoglobin HbA1C of 6.0–6.4%.2 The criteria proposed by the American Diabetes Association, on the other hand, were less stringent, with a fasting blood glucose of 5.6–6.9 mmol/L or a 2-hour post-load plasma glucose of 7.8–11.0 or a glycated hemoglobin HbA1C of 5.7–6.4% as fulfilling prediabetes.2 Prediabetes represents an important public health concern that is both preventable and reversible. Early intervention has been shown to hold the promise of reversing prediabetes to normoglycemia.3

Although the exact etiopathogenesis of prediabetes remains largely unknown, mounting evidence suggests that the gut microbiota may be implicated in the pathogenesis of prediabetes.4 Contemporary researches revealed that, in addition to its function in digestion and nutrient absorption, the gut flora is also involved in the onset of various medical conditions. For instance, a large population-based study found that the insulin resistance in prediabetes and diabetes were predominantly responsible for the microbial variations observed.5 Moreover, alterations in the composition or density of the gut microbiota, especially a reduction in the population of butyrate-producing bacteria, have been documented to promote impaired glucose tolerance and reduce insulin sensitivity, leading to prediabetes and subsequently overt type 2 diabetes.6 A previous comparative study revealed that prediabetes is characterized by a significantly higher abundance of the genus from the family Pseudonocardiaceae as compared to healthy controls and type 2 diabetes.7 Another study found a decreased abundance of the genus Clostridium and the mucin-degrading bacterium A. muciniphila in patients with prediabetes.8 In light of these findings, intervention measures targeting the gut microbiota may represent a promising strategy for ameliorating prediabetes.

Dietary intervention represents a simple method for supplementing live microorganisms. Available studies in the literature have reported that dietary live microbes intake were beneficial for a variety of health conditions, such as depression, obesity, kidney stone, and even a lower mortality risk.9–12 Thus, dietary live microbes may serve as an effective and convenient intervention strategy for prediabetes management. The relationships between overall dietary intake of live microbes and risk of prediabetes has not been fully elucidated. We hypothesized that higher intakes of dietary live microbes would be associated with a lower risk of prediabetes. To bridge this gap, the present study aimed to assess the associations between dietary intake of live microbes as assessed by the Sanders’ method and the prevalence of prediabetes in US adults.

Methods

Study Participants

The participants of the current study were derived from the ten cycles (1999–2018) of the US National Health and Nutrition Examination Survey (NHANES), which is a nationwide cross-sectional survey designed to obtain data on the health and nutritional status of non-institutionalized US citizens. The detailed operational procedure has been previously outlined, and the health-related data are publicly and freely available at https://wwwn.cdc.gov/nchs/nhanes/Default.aspx. The cross-sectional design of NHANES could only be used to determine associations, not to establish causality between dietary intake of live microbes and risk of prediabetes. The NHANES protocol was approved by the NCHS Research Ethics Review Board, with informed consent obtained from all adult participants. According to the Item 1 and 2 of Article 32 of the Measures for Ethical Review of Life Science and Medical Research Involving Human Subjects dated February 18, 2023, China, this study is exempted from ethical approval from our institution since it used anonymized and publicly available data without incurring any potential dangers to the participants.

We restricted our study sample to adult participants with available data on glycemic status and dietary intake of live microbes. The exclusion criteria were participant age less than 20 years (n = 16,361), pregnancy (n = 1438), missing dietary intake of live microbes (n = 6988), and missing data of covariates (n = 7419). As presented in Figure 1, 28201 participants were eligible for inclusion into the final analysis.

Figure 1 Flowchart of the inclusion and exclusion process of the participants.

Abbreviations: BMI, body mass index; HDL, high-density lipoprotein cholesterol; NHANES, national health and nutrition examination survey; PIR, poverty–income ratio; TC, total cholesterol; TG, triglyceride.

Primary Exposure

Dietary live microbes intake, as assessed by the Sanders’ method proposed by Marco et al, serves as the primary exposure of this study.13 Dietary information was obtained from the first face-to-face 24-hour dietary recall. Four experts in the Marco’s group evaluated the content of live microbes per gram for each of the 9388 food codes across 48 subgroups included in the NHANES dataset. In brief, live microbe level was broadly categorized as low (<104 colony-forming units per gram), medium (104–107 colony-forming units per gram), or high (>107 colony-forming units per gram), respectively, according to published references, expert opinions and also in consideration of the techniques of food processing. Any discrepancies were resolved through discussion within the team and consultation with expert microbiologist Fred Breidt from the US Department of Agriculture. This method has been used extensively in prior studies to estimate the relative abundance of live microbes.9–12 Participants were grouped into the low, medium and high dietary live microbe intake group, as previously reported.14

Primary Outcome

Prediabetes status is the primary outcome of this study, defined as self-report, or 5.6 mmol/L ≤ fasting blood glucose < 7.0 mmol/L, or 5.7% ≤ HbA1C < 6.5%, or a 2-hour post-load oral glucose tolerance test blood glucose of 7.8–11.0 mg/dL.15

Assessment of Covariates

Variables with the potential to be associated with dietary live microbes and prediabetes were collected and included. Specifically, the following parameters were included in the analysis: participant’s age, sex, race/ethnicity, education level, poverty–income ratio, marital status, body mass index, alcohol consumption, cigarette use, hypertension, history of cardiovascular disease, physical activity, statin use, total dietary energy intake, and laboratory tests of triglyceride, total cholesterol, high-density lipoprotein cholesterol, uric acid, and estimated glomerular filtration rate. The definitions and categorization criteria for hypertension, diabetes, smoking, drinking, and physical activity were the same as reported previously.16,17 The calculation of the estimated glomerular filtration was based on the 2009 serum creatinine-based CKD-EPI formula.18 Physical activity included both work and leisure activities in a typical week that lasted at least 10 consecutive minutes and was categorized as none, moderate (requiring moderate physical effort and causing small increases in breathing or heart rate), and vigorous (requiring heavy physical effort and causing large increases in breathing or heart rate). Alcohol use was also categorized into never (<12 drinks in lifetime), former drinkers (≥12 drinks in lifetime but not in the last year), mild (≤1 drink per day for females or ≤2 drinks per day for males, on average over the past year), moderate (≤2 drinks per day for females, ≤3 drinks per day for males, or binge drinking on 2–5 days per month), and heavy (≥3 drinks per day for females, ≥4 drinks per day for males, or binge drinking ≥5 days per month).

Statistical Analysis

Statistical analysis was performed in accordance with the NHANES analytic recommendations, with appropriate weighting employed to obtain nationally representative estimates. The participants' characteristics were expressed as mean ± standard error or counts (weighted percentages), as appropriate, and compared weighted one-way analysis of variance or chi-squared test, respectively. The relationships between dietary intake of live microbes and the prevalence of prediabetes were explored using the logistic regression under 4 models in total. The Model 1 was unadjusted, while the Model 2 was adjusted for participant’s age, sex, race, poverty–income ratio, marital status, and education level. The Model 3 was adjusted for Model 2 plus body mass index, smoking, alcohol consumption, hypertension status, physical activity, and history of cardiovascular disease. The Model 4 was further adjusted for triglyceride, total cholesterol, high-density lipoprotein cholesterol, uric acid, estimated glomerular filtration rate and dietary total energy intake. Stratified regression analyses were employed to account for differences as a function of participant’s age, sex, race, poverty–income ratio, education level, hypertension status and estimated glomerular filtration rate. A two-side P value <0.05 was considered statistical significance.

Results

Baseline Characteristics of Study Participants

Table 1 presents the comparison of baseline characteristics of the study participants stratified by dietary live microbe intake. Among the 28201 participants (mean age 45.83 years, 48.40% men) included, 9761 (31.80%), 12,076 (41.42%), and 6364 (26.78%) were classified into the low, medium, and high dietary live microbe intake groups, respectively. Compared to the low dietary live microbe intake group, the high dietary live microbe intake group were significantly older, more likely to be women and non-Hispanic white, less likely to be single, more educated with higher poverty–income ratio, associated with lower body mass index, less likely to be current smokers and heavy drinkers, less likely to have hypertension and cardiovascular diseases, and less likely to be physically inactive. In terms of laboratory findings, the high dietary live microbe intake group were associated with significantly lower uric acid, triglyceride, estimated glomerular filtration rate, and more likely to have higher total cholesterol, high-density lipoprotein cholesterol, and statin use, in comparison to the low dietary live microbe intake group. Notably, the high dietary live microbe intake group exhibited the lowest prevalence of prediabetes at 30.96%, followed by the medium intake group at 33.04%, in comparison to the highest prevalence of prediabetes of 33.97% in the low dietary microbe intake group.

Table 1 Comparison of Participant’s Characteristics Based Upon Different Dietary Consumption of Live Microbes

Association Between Dietary Live Microbe Intake and Prediabetes Risk

Table 2 shows the associations between dietary live microbe intake and the likelihood of prediabetes with and without covariate adjustment. In the crude analysis, medium and high dietary live microbe intake was associated with 17.4% and 20.6% decreased risk of prediabetes, respectively, as compared to the low dietary live microbe intake group. After adjustment for all covariates, the Model 4 showed the odds ratios and 95% confidence intervals for the medium and high dietary live microbe intake were 0.868 (0.803–0.937) and 0.891 (0.807–0.983), respectively (P for trend = 0.017), with the low dietary live microbe intake group as the reference.

Table 2 Associations Between Dietary Live Microbes Intake and Prevalence of Prediabetes

Subgroup Analysis

The stratified analysis, shown in Table 3, indicated that participant’s age, sex, race, poverty–income ratio, education level, hypertension status and estimated glomerular filtration rate did not significantly modify the relationship between dietary microbes intake and risk of prediabetes.

Table 3 Subgroup Analysis for the Associations Between Dietary Live Microbes Intake and Prevalence of Prediabetes

Sensitivity Analysis

We performed the sensitivity analysis by also incorporating prebiotic or probiotic intake from the supplement. There were 496 and 409 participants who took prebiotics and probiotics, respectively, and 14060 and 14147 participants who did not take prebiotics and probiotics, respectively. Similar to the main results, sensitivity analysis after adjusting for all covariates also showed decreased risk for prediabetes in participants with higher dietary live microbes intake (Table 4).

Table 4 Sensitivity Analysis for the Associations Between Dietary Live Microbes Intake and Prevalence of Prediabetes

Discussion

To the best of our knowledge, this study represents the inaugural investigation into the relationship between dietary intake of live microbes and the prevalence of prediabetes in a nationally representative sample. The results showed that a higher dietary intake of live microbes was associated with a reduced prevalence of prediabetes in US adults even after adjusting for a range of confounding variables. In addition, this association was found to be robust and did not appear to be modified by participant’s age, sex, race, poverty–income ratio, education level, hypertension status, or kidney function. The preliminary results of this study imply that a diet rich in live microbes may potentially serve as a protective factor against the development of prediabetes.

Indeed, compositional shifts of the gut microbiota in individuals with type 2 diabetes have been extensively characterized previously, with relatively less attention devoted to prediabetes. Chang et al identified a reduction in the abundance of nine bacterial genera and an increase in the abundance of 14 in individuals with prediabetes in comparison to healthy controls.19 A recent comprehensive review indicated a decreased abundance of genus Clostridium, A. Muciniphila, phylum Firmicutes, Lactobacillus plantarum HAC01, Faecalibacterium prausnitzii, and an increased abundance of Ruminococcus, Streptococcus, Chloracidobacterium and Pseudonocardiaceae in patients with prediabetes as compared with normoglycemic individuals.20 In addition to these cross-sectional observations, Takeuchi’s group provided evidence of a causal relationship between specific gut bacteria and insulin resistance, which is an early feature of prediabetes.21

The human diet provides a rich and convenient source of living microorganisms that have the potential to significantly influence the composition, function and diversity of gut microbiome. The content of bacteria, yeasts and other fungi in the diet varies significantly according to the specific food types, preparation and processing techniques, and duration of food storage. Earlier studies have revealed associations between certain dietary patterns and microbial composition, highlighting that habitual intake plays a critical role in modulating the gut microbial profile. For instance, Wastyk’s 17-week randomized trial showed that compared with a high-fiber diet, a fermented-food diet could increase microbiome diversity and decrease inflammatory markers.22 Animal studies also showed that an energy-restricted diet including yogurt, fruits and vegetables could ameliorate metabolic syndrome by increasing the Akkermansia bacteria by 3.5-fold.23 Although the exact mechanisms underlying the beneficial health effects of dietary live microbes have not been completely understood, previous studies employing Sander’s classification method have also documented a range of positive health effects for conditions like frailty, depression, diabetic kidney disease, and chronic obstructive pulmonary disease.24–27

In light of the intimate association between gut flora and diabetes, there is a growing interest in the scientific community to manipulate gut microbiota for the prevention and treatment of prediabetes. We are aware that various techniques have been employed to manipulate gut microbiota for the amelioration of diabetes, such as fecal microbiota transplantation, increased dietary fiber intake, and probiotics supplementation.28 Of note, the current study demonstrated that a high dietary intake of live microbes was more strongly associated with a reduced risk of prediabetes than a medium intake of live microbes, which is compatible with several prior reports but contradicts others. The report from Liu et al showed a negative correlation between dietary live microbes intake and risk of rheumatoid arthritis.29 However, Tang et al and Han et al reported that diets with medium live microbes are more strongly associated with cognitive function and cardiovascular disease, respectively.30,31

Although the precise mechanisms underlying the beneficial effects of live microbes for prediabetes remain elusive, we hypothesize that the following mechanisms may be potentially involved in this association. First, dietary living microorganisms may reduce the concentrations of branched-chain amino acids, thereby alleviating insulin resistance.32 The branched-chained amino acids have been found to promote insulin resistance by continuously activating mammalian rapamycin complex 1 via insulin receptor substrate 1 phosphorylation.33 Second, the dietary live microbes could boost immune response and reduce inflammatory cytokine production, which in turn would decrease pancreatic β cell injury from external pathogenic microorganisms.34 Ultimately, the protective effect of dietary live microbes for prediabetes may be related to its ability to reduce oxidative stress,35 a critical pathophysiologic process involved in pancreatic β cell injury and exhaustion.

In the sensitivity analysis, we also excluded the confounding effects of probiotics and prebiotics, given that both have been shown to exert health effects. Prebiotics are selectively fermented ingredients degraded by gut microbiota to stimulate the growth and activity of beneficial bacteria in the gut. Probiotics, on the other hand, are living microorganisms, such as Lactobacillus, Lactococcus, Leuconostoc, and other typically found in kefir and yogurt. A recent meta-analysis of randomized controlled trials in prediabetes demonstrated that probiotics could decrease glycated hemoglobin and improve post-load glycemic levels.36 Although the use of prebiotics did not appear to improve glycemic control, it has been shown to alter gut microbiota composition.37 Therefore, the results of the sensitivity analysis provide further evidence in support of the hypothesis that dietary live microbes exert a beneficial effect on prediabetes.

Our study may have some practical implications for dietary interventions. The findings may potentially suggest that the amount of live microbes should also be incorporated into dietary recommendations to promote health. For instance, foods rich in live microorganisms, such as fruits, vegetables, yogurt, and other fermented foods, may be recommended for individuals at high risk of developing prediabetes. Future studies should apply alternative methods to accurately quantify dietary live microbes and prospectively determine their potential utility in preventing prediabetes.

The strength of the present study includes the use of nationally representative data, thereby enabling the external applicability of study results across broader contexts. Moreover, we also considered a range of sociodemographic characteristics, health-related variables, and prebiotics and probiotics that might introduce potential confounding influences. This study also suffers from several limitations that warrant further consideration. First, the cross-sectional design of NHANES made it difficult to establish a causal relationship between dietary intake of live microbes and prevalence of prediabetes. Second, although the Sanders’ classification method has been successfully applied for the categorization of dietary microbial content, it is imprecise and subject to bias. Thus, methods for the precise calculation of dietary viable microorganisms and the optimal dose of live microorganisms needs to be further explored in the future. Third, the calculation of dietary live microorganisms is derived from self-report dietary intake, which would be subject to recall bias and may not be representative of habitual dietary habits. In addition, this study included individuals with self-reported prediabetes, which is another source of recall bias. Fourth, the participant selection and exclusion process may introduce selection bias and limit the generalizability of the study findings to a wider population. Finally, despite the adjustment for a range of potential confounding variables, the possibility of residual confounding factors, such as the use of antibiotics or other medications on gut microbiota composition, cannot be completely excluded.

Conclusion

In conclusion, this cross-sectional study based on national survey data showed a negative association between dietary live microbe intake and prevalence of prediabetes in US adults. The results suggest that dietary counseling to increase intake of foods rich in live microbes may be helpful in reducing the risk of prediabetes. Given the cross-sectional study design and the imprecision of the Sanders’ classification system, prospective large-scale randomized clinical trials are needed in the future to definitively establish a causal relationship between dietary live microorganism consumption and risk of prediabetes.

Data Sharing Statement

This study was carried out using publicly available data from the US National Health and Nutrition Examination Survey at https://www.cdc.gov/nchs/nhanes/.

Ethics Approval and Consent to Participate

The NHANES protocol was approved by the NCHS Research Ethics Review Board, with informed consent obtained from all adult participants.

Funding

This study was supported by the Research Fund of Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine (No. TRYJ2021LC08 and TRYJ2022LC05), Clinical research project of Shanghai Municipal Health Commission (No. 202340014), and The Rising Star Programme in Tongren Hospital (No. TRKYRC-xx202209).

Disclosure

Xiaoxu Ge, Juan Du and Jiajia Wang are co-first authors. The authors report no conflicts of interest in this work.

References

1. Rooney MR, Fang M, Ogurtsova K, et al. Global prevalence of prediabetes. Diabetes Care. 2023;46(7):1388–1394. doi:10.2337/dc22-2376

2. Warren B, Pankow JS, Matsushita K, et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the atherosclerosis risk in communities (ARIC) study. Lancet Diabetes Endocrinol. 2017;5(1):34–42. doi:10.1016/S2213-8587(16)30321-7

3. Liu X, Wu S, Song Q, Wang X. Reversion from pre-diabetes mellitus to normoglycemia and risk of cardiovascular disease and all-cause mortality in a Chinese population: a prospective cohort study. J Am Heart Assoc. 2021;10(3):e019045. doi:10.1161/JAHA.120.019045

4. Huang Q, Fang Q, Hu Z. A P4 medicine perspective of gut microbiota and prediabetes: systems analysis and personalized intervention. J Transl Int Med. 2020;8(3):119–130. doi:10.2478/jtim-2020-0020

5. Wu H, Tremaroli V, Schmidt C, et al. The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study. Cell Metab. 2020;32(3):379–390.e3. doi:10.1016/j.cmet.2020.06.011

6. Cui J, Ramesh G, Wu M, et al. Butyrate-producing bacteria and insulin homeostasis: the microbiome and insulin longitudinal evaluation study (MILES). Diabetes. 2022;71(11):2438–2446. doi:10.2337/db22-0168

7. Lambeth SM, Carson T, Lowe J, et al. Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes. J Diabetes Obes. 2015;2(3):1–7. doi:10.15436/2376-0949.15.031

8. Allin KH, Tremaroli V, Caesar R, et al. Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia. 2018;61(4):810–820. doi:10.1007/s00125-018-4550-1

9. Shi J, Zhao Q, Liang Z, et al. Association of dietary intake of live microbes with bowel health and depression in US adults: a cross-sectional study of NHANES 2005-2010. Environ Health Prev Med. 2024;29:75. doi:10.1265/ehpm.24-00202

10. Liang JH, Pu YQ, Yang XZ, et al. Mediating effect of physical activity on the relationship between high dietary live microbe intake and obesity among U.S adolescents, finding from NHANES 1999-2018. Nutr, Metab Cardiovasc Dis. 2024. doi:10.1016/j.numecd.2024.103786

11. Zheng Z, Cao X. Association of dietary live microbe intake with kidney stone disease in US adults: a real-world cross-sectional study. Front Nutr. 2024;11:1463352. doi:10.3389/fnut.2024.1463352

12. Zhu X, Chen W, Xue J, et al. Dietary live microbes intake associated with biological aging and mortality. J Gerontol a Biol Sci Med Sci. 2024;79(11):glae202. doi:10.1093/gerona/glae202

13. Marco ML, Hutkins R, Hill C, et al. A classification system for defining and estimating dietary intake of live microbes in US adults and children. J Nutr. 2022;152(7):1729–1736. doi:10.1093/jn/nxac074

14. Gu S, Jiang C, Yu Z, Yang W, Wu C, Shao Y. The relationship between dietary intake of live microbes and insulin resistance among healthy adults in the US: a cross-sectional study from NHANES 2003-2020. Sci Rep. 2024;14(1):17666. doi:10.1038/s41598-024-68243-8

15. Kong X, Wang W. Estimated glucose disposal rate and risk of cardiovascular disease and mortality in U.S. adults with prediabetes: a nationwide cross-sectional and prospective cohort study. Acta Diabetol. 2024;61(11):1413–1421. doi:10.1007/s00592-024-02305-1

16. Kong X, Wang W. Associations between the composite dietary antioxidant index and abdominal aortic calcification among United States adults: a cross-sectional study. JPEN J Parenter Enteral Nutr. 2024;48(5):571–579. doi:10.1002/jpen.2638

17. Evenson KR, Wen F. National trends in self-reported physical activity and sedentary behaviors among pregnant women: NHANES 1999-2006. Prev Med. 2010;50(3):123–128. doi:10.1016/j.ypmed.2009.12.015

18. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006

19. Chang WL, Chen YE, Tseng HT, Cheng CF, Wu JH, Hou YC. Gut microbiota in patients with prediabetes. Nutrients. 2024;16(8):1105. doi:10.3390/nu16081105

20. Rathi KK, Kumari N, Javaid MD, et al. Gut microbiome and prediabetes - a review. Front Bacteriol. 2023;2:1242297. doi:10.3389/fbrio.2023.1242297

21. Takeuchi T, Kubota T, Nakanishi Y, et al. Gut microbial carbohydrate metabolism contributes to insulin resistance. Nature. 2023;621(7978):389–395. doi:10.1038/s41586-023-06466-x

22. Wastyk HC, Fragiadakis GK, Perelman D, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137–4153.e14. doi:10.1016/j.cell.2021.06.019

23. Kong CY, Li ZM, Chen HL, et al. An energy-restricted diet including yogurt, fruit, and vegetables alleviates high-fat diet-induced metabolic syndrome in mice by modulating the gut microbiota. J Nutr. 2022;152(11):2429–2440. doi:10.1093/jn/nxac181

24. Huo X, Jia S, Sun L, Yao Y, Liao H, Chen X. Association of dietary live microbe intake with frailty in US adults: evidence from NHANES. J Nutr Health Aging. 2024;28(3):100171. doi:10.1016/j.jnha.2024.100171

25. Wang X, Wang H, Yu Q, et al. High dietary live microbe intake is correlated with reduced risk of depressive symptoms: a cross-sectional study of NHANES 2007-2016. J Affect Disord. 2024;344:198–206. doi:10.1016/j.jad.2023.10.015

26. Wang M, Huang ZH, Zhu YH, et al. Association of dietary live microbe intake with diabetic kidney disease in patients with type 2 diabetes mellitus in US adults: a cross-sectional study of NHANES 1999-2018. Acta Diabetol. 2024;61(6):705–714. doi:10.1007/s00592-023-02231-8

27. Zhou D, He B, Huang Q, et al. Relationship between dietary live microbe intake and the prevalence of COPD in adults: a cross-sectional study of NHANES 2013-2018. BMC Pulm Med. 2024;24(1):225. doi:10.1186/s12890-024-03045-2

28. Wu Z, Zhang B, Chen F, et al. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: a randomized, controlled, prospective study. Front Cell Infect Microbiol. 2023;12:1089991. doi:10.3389/fcimb.2022.1089991

29. Liu Y, Xing Y, Kong X. Exploratory analysis on the relationship between dietary live microbe intake and arthritis: a national population based cross-sectional study. Front Nutr. 2024;10:1328238. doi:10.3389/fnut.2023.1328238

30. Tang H, Zhang X, Luo N, Huang J, Zhu Y. Association of dietary live microbes and nondietary prebiotic/probiotic intake with cognitive function in older adults: evidence from NHANES. J Gerontol a Biol Sci Med Sci. 2024;79(2):glad175. doi:10.1093/gerona/glad175

31. Han L, Wang Q. Association of dietary live microbe intake with cardiovascular disease in US adults: a cross-sectional study of NHANES 2007-2018. Nutrients. 2022;14(22):4908. doi:10.3390/nu14224908

32. Gojda J, Cahova M. Gut microbiota as the link between elevated BCAA serum levels and insulin resistance. Biomolecules. 2021;11(10):1414. doi:10.3390/biom11101414

33. Yoon MS, Choi CS. The role of amino acid-induced mammalian target of rapamycin complex 1(mTORC1) signaling in insulin resistance. Exp Mol Med. 2016;48(1):e201. doi:10.1038/emm.2015.93

34. Semo D, Reinecke H, Godfrey R. Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity. Signal Transduct Target Ther. 2024;9(1):35. doi:10.1038/s41392-024-01746-y

35. Zeng Z, Yuan Q, Yu R, Zhang J, Ma H, Chen S. Ameliorative effects of probiotic lactobacillus paracasei NL41 on insulin sensitivity, oxidative stress, and beta-cell function in a type 2 diabetes mellitus rat model. mol Nutr Food Res. 2019;63(22):e1900457. doi:10.1002/mnfr.201900457

36. Wang X, Yang J, Qiu X, et al. Probiotics, pre-biotics and synbiotics in the treatment of pre-diabetes: a systematic review of randomized controlled trials. Front Public Health. 2021;9:645035. doi:10.3389/fpubh.2021.645035

37. Barengolts E. Gut MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED Trials. Endocr Pract. 2016;22(10):1224–1234. doi:10.4158/EP151157.RA

Creative Commons License © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.